Skip to main content

Market Overview

38 Stocks Moving in Thursday's Pre-Market Session

Share:
38 Stocks Moving in Thursday's Pre-Market Session

Gainers

  • Birks Group Inc. (NYSE: BGI) rose 150.4% to $2.00 in pre-market trading after the company reported a 12.2% year-over-year growth in FY20 sales.
  • CynergisTek, Inc. (NYSE: CTEK) rose 41.1% to $2.40 in pre-market trading after the company announced it secured roughly $950,000 in renewals.
  • Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares rose 40.4% to $1.46 in pre-market trading after the company was granted Australian patent titled ‘Treatment of cancers using PI3 kinase isoform modulators.’
  • Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares rose 28% to $1.37 in pre-market trading after gaining over 10% on Wednesday.
  • Myomo, Inc. (NYSE: MYO) rose 27% to $4.70 in pre-market trading after the company highlighted the launch of MyoCare, a program to provide enhanced support to first-year users of MyoPro powered brace.
  • OptiNose Inc (NASDAQ: OPTN) rose 22.4% to $5.20 in pre-market trading after the company announced it signed an agreement with kaleo to co-promote XHANCE.
  • Qudian Inc. (NYSE: QD) rose 22.1% to $3.20 in pre-market trading after jumping over 36% on Wednesday.
  • EXFO Inc. (NASDAQ: EXFO) rose 19.6% to $3.85 in pre-market trading after the company reported better-than-expected Q3 sales.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) rose 18.7% to $0.56 in pre-market trading.
  • Acer Therapeutics Inc. (NASDAQ: ACER) rose 16.5% to $3.75 in pre-market trading after the company reported its ACER-001, based on modeling data, may improve disease management in patients with urea cycle disorders compared to currently approved treatments requiring administration with food.
  • Bluecity Holdings (NASDAQ: BLCT) rose 15.7% to $27.10 in pre-market trading. Bluecity shares surged 46% on Wednesday after the company priced its IPO at $16 per ADS.
  • Cheetah Mobile Inc. (NYSE: CMCM) rose 14.8% to $2.72 in pre-market trading after climbing more than 30% on Wednesday.
  • Ocugen, Inc. (NASDAQ: OCGN) rose 14.8% to $0.24 in pre-market trading.
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) rose 14% to $9.14 in pre-market trading after the company reported formation of clinical testing subsidiary to maximize utility of the FDA emergency use authorization-approved linea coronavirus assay Kit.
  • Landcadia Holdings II, Inc. (NASDAQ: LCA) rose 12.8% to $13.87 in pre-market trading.
  • UP Fintech Holding Limited (NASDAQ: TIGR) rose 10.3% to $7.61 in pre-market trading after jumping over 25% on Wednesday.
  • Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) rose 10.1% to $7.00 in pre-market trading after the company received the FDA approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic solution), 0.1% for acquired blepharoptosis (droopy eyelid) in adults.
  • Veritone, Inc. (NASDAQ: VERI) shares rose 9.9% to $13.35 in pre-market trading after the company raised its Q2 guidance.
  • NetEase, Inc. (NASDAQ: NTES) rose 9.1% to $496.00 in pre-market trading.
  • Niu Technologies (NASDAQ: NIU) rose 8.7% to $24.92 in pre-market trading.
  • NIO Inc. (NYSE: NIO) rose 8.5% to $13.98 in pre-market trading.
  • Novan, Inc. (NASDAQ: NOVN) rose 7.9% to $0.5330 in pre-market trading.
  • SAP SE (NYSE: SAP) rose 7.3% to $157.73 in pre-market trading after the company reported an 8% rise in Q2 non-IFRS operating profit and reaffirmed its FY20 guidance.
  • Nikola Corporation (NASDAQ: NKLA) rose 7.2% to $57.90 in pre-market trading. Nikola shares jumped more than 34% on Wednesday after JP Morgan upgraded the company's stock from Neutral to Overweight and announced a $45 price target.
  • Sibanye Stillwater Limited (NYSE: SBSW) rose 7% to $10.35 in pre-market trading.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) rose 7% to $1.07 in pre-market trading after gaining 11% on Wednesday.
  • CHF Solutions, Inc. (NASDAQ: CHFS) rose 6.1% to $0.61 in pre-market trading. On Wednesday, CHF Solutions and RenalSense announced a distribution partnership to offer ultrafiltration and real-time diagnostics.
  • Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) rose 5.7% to $2.79 in pre-market trading.

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Hudson Capital Inc. (NASDAQ: HUSN) fell 12.2% to $0.7370 in pre-market trading after gaining over 32% on Wednesday.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 10.3% to $9.34 in pre-market trading after the company reported a wider-than-expected loss for its first quarter and announced plans to close 200 stores in the next two year.
  • NanoViricides, Inc. (NYSE: NNVC) shares fell 8.9% to $7.95 in pre-market trading. NanoViricides priced its 1.37 million share offering at $7.30 per share.
  • Otonomy Inc (NASDAQ: OTIC) fell 7.3% to $3.30 in pre-market trading after the company disclosed a proposed public offering.
  • Unum Therapeutics Inc. (NASDAQ: UMRX) fell 7.1% to $2.75 in pre-market trading after jumping about 24% on Wednesday.
  • Ideanomics, Inc. (NASDAQ: IDEX) fell 7.1% to $1.45 in pre-market trading following a 24% surge on Wednesday.
  • BIOLASE, Inc. (NASDAQ: BIOL) fell 6.5% to $0.4110 in pre-market trading. On Wednesday, BIOLASE disclosed that its Hygiene laser has met CDC guidelines to minimize the risk of COVID-19 transmission.
  • National Grid plc (NYSE: NGG) fell 6.2% to $53.82 in pre-market trading.
  • Vislink Technologies, Inc. (NASDAQ: VISL) shares fell 5.9% to $0.5839 in pre-market trading after gaining over 5% on Wednesday.
  • MYOS RENS Technology Inc. (NASDAQ: MYOS) fell 5.4% to $1.40 in pre-market trading.
 

Related Articles (APDN + ACER)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com